Healio

FDA accepts investigational new drug application for Eluminex DME treatment

Please provide your email address to receive an email when new articles are posted on . EB-105 is a trispecific fusion antibody for the treatment of diabetic macular edema. Eluminex is seeking ...
Business Wire

FDA Accepts Application for Genentech’s Faricimab for the Treatment of Wet Age-Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME)

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the ...
FiercePharma

pSivida Corp. Reports Alimera’s Intention to Resubmit Application to FDA for ILUVIEN® in DME Using Data from Completed Trials

pSivida Corp. Reports Alimera’s Intention to Resubmit Application to FDA for ILUVIEN® in DME Using Data from Completed Trials Martin E. Janis & Company, Inc.Beverly Jedynak, +1 (312) 943 ...
FiercePharma

pSivida Corp. Reports Alimera's Intention to Resubmit Application to FDA for ILUVIEN® in DME Using Data from Completed Trials

pSivida Corp. Reports Alimera's Intention to Resubmit Application to FDA for ILUVIEN® in DME Using Data from Completed Trials WATERTOWN, Mass.--(BUSINESS WIRE)-- pSivida Corp. (NASDAQ: PSDV) (ASX: PVA ...
FierceBiotech

pSivida Corp. Reports Alimera’s Intention to Resubmit Application to FDA for ILUVIEN® in DME Using Data from Completed Trials

pSivida Corp. Reports Alimera’s Intention to Resubmit Application to FDA for ILUVIEN® in DME Using Data from Completed Trials Martin E. Janis & Company, Inc.Beverly Jedynak, +1 (312) 943 ...